Chi-Ying F. Huang

Affiliations: 
Institute of Clinical Medicine National Yang-Ming University, Allendale Charter Township, Taipei City, Taiwan 
Google:
"Chi-Ying Huang"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wen KC, Sung PL, Wu ATH, et al. (2020) Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer. Journal of Ovarian Research. 13: 95
Chuang YC, Tseng JC, Huang LR, et al. (2020) Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade. Frontiers in Immunology. 11: 1075
Wu WH, Li FY, Shu YC, et al. (2020) Oncogene inference optimization using constraint-based modelling incorporated with protein expression in normal and tumour tissues. Royal Society Open Science. 7: 191241
Lu HJ, Hsieh CC, Yeh CC, et al. (2019) Clinical, pathophysiologic, and genomic analysis of the outcomes of primary head and neck malignancy after pulmonary metastasectomy. Scientific Reports. 9: 12913
Hsu YB, Lan MC, Kuo YL, et al. (2019) A preclinical evaluation of thiostrepton, a natural antibiotic, in nasopharyngeal carcinoma. Investigational New Drugs
Lu H, Liu H, Hang J, et al. (2019) Genomic profiling for unfavorable carcinoma of unknown primary patients. Journal of Clinical Oncology. 37: e13140-e13140
Chang PM, Chen CH, Yeh CC, et al. (2018) Transcriptome analysis and prognosis of ALDH isoforms in human cancer. Scientific Reports. 8: 2713
Huang T, Hsu H, Huang CF. (2018) Abstract LB-051: An Astragalus-based Chinese herbal medicine extraction inhibits cancer stem cell growth and sensitizes of drug-resistant human non-small cell lung cancer cells for targeted therapy Cancer Research. 78
Lu H, Hsieh C, Yeh C, et al. (2018) Abstract 3442: Genome-wide association study reveals potential biomarkers after pulmonary metastasectomy for head and neck cancer Cancer Research. 78: 3442-3442
Yeh CN, Chang YC, Su Y, et al. (2017) Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients. Oncotarget. 8: 113444-113459
See more...